Suppression of nasopharyngeal carcinoma cell by targeting β-catenin signaling pathway

Cancer Epidemiology

Volumn 36, Issue 2, 2012, Pages

  Song, Yulan ^a,b   Yang, Qing Xu ^c   Zhang, Fenfen ^a   Meng, Fengjiao ^a   Li, Hui ^a   Dong, Yu ^a   Han, Anjia ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c HUIZHOU MUNICIPAL CENTRAL HOSPITAL   (China)

Author keywords

Catenin; Apoptosis; Invasion; Nasopharyngeal carcinoma; Proliferation

Indexed keywords

BETA CATENIN; CYCLIN D1; GELATINASE A; GELATINASE B; KI 67 ANTIGEN; MYC PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NASOPHARYNX CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BETA CATENIN; BLOTTING, WESTERN; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; UP-REGULATION; YOUNG ADULT;

EID: 84858795807     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.11.002     Document Type: Article

References (22)

1. Chou J., Lin Y.C., Kim J., You L., Xu Z., He B., et al. Nasopharyngeal carcinoma: review of the molecular mechanisms of tumorigenesis. Head Neck 2008, 30:946-963.
2. Liu Q., Han A., You S., Yang Q., Liang Y., Dong Y. The association of genomic variation of Epstein-Barr virus BamHI F fragment with the proliferation of nasopharyngeal carcinoma. APMIS 2010, 118:657-664.
3. Yu M.C., Ho J.H., Ross R.K., Henderson B.E. Nasopharyngeal carcinoma in Chinese: salted fish or inhaled smoke?. Prev Med 1981, 10:15-24.
4. Jou T.S., Stewart D.B., Stappert J., Nelson W.J., Marrs J.A. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci U S A 1995, 92:5067-5071.
5. Ge X., Wang X. Role of Wnt canonical pathway in hematological malignancies. J Hematol Oncol 2010, 3:33.
6. Nakashima N., Huang C.L., Liu D., Ueno M., Yokomise H. Intratumoral Wnt1 expression affects survivin gene expression in non-small cell lung cancer. Int J Oncol 2010, 37:687-694.
7. Biechele T.L., Camp N.D., Fass D.M., Kulikauskas R.M., Robin N.C., White B.D., et al. Chemical-genetic screen identifies riluzole as an enhancer of Wnt/beta-catenin signaling in melanoma. Chem Biol 2010, 17:1177-1182.
8. Song J., Chang I., Chen Z., Kang M., Wang C.Y. Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling. PLoS One 2010, 5:e11456.
9. Han A., Song Z., Tong C., Hu D., Bi X., Augenlicht L.H., et al. Sulindac suppresses beta-catenin expression in human cancer cells. Eur J Pharmacol 2008, 583:26-31.
10. Han A., Tong C., Hu D., Bi X., Yang W. A direct protein-protein interaction is involved in the suppression of beta-catenin transcription by retinoid X receptor alpha in colorectal cancer cells. Cancer Biol Ther 2008, 7:454-459.
11. Chikazawa N., Tanaka H., Tasaka T., Nakamura M., Tanaka M., Onishi H., et al. Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells. Anticancer Res 2010, 30:2041-2048.
12. Choi M.G., Sung C.O., Noh J.H., Kim K.M., Sohn T.S., Kim S., et al. Mucinous gastric cancer presents with more advanced tumor stage and weaker beta-catenin expression than nonmucinous cancer. Ann Surg Oncol 2010, 17:3053-3058.
13. Li J., Ying J., Fan Y., Wu L., Ying Y., Chan A.T., et al. WNT5A antagonizes WNT/beta-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Cancer Biol Ther 2010, 10:617-624.
14. Hirata H., Hinoda Y., Nakajima K., Kawamoto K., Kikuno N., Ueno K., et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int J Cancer 2011, 128:1793-1803.
15. You S., Zhang F., Meng F., Li H., Liu Q., Liang Y., et al. EBV-encoded LMP1 increases nuclear beta-catenin accumulation and its transcriptional activity in nasopharyngeal carcinoma. Tumour Biol 2011, 32:623-630.
16. Maruyama K., Ochiai A., Akimoto S., Nakamura S., Baba S., Moriya Y., et al. Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncol Basel 2000, 59:302-309.
17. Raybaud-Diogene H., Fortin A., Morency R., Roy J., Monteil R.A., Tetu B. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol 1997, 15:1030-1038.
18. Zeng Z.Y., Zhou Y.H., Zhang W.L., Xiong W., Fan S.Q., Li X.L., et al. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 2007, 38:120-133.
19. Shi W., Bastianutto C., Li A., Perez-Ordonez B., Ng R., Chow K.Y., et al. Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer 2006, 119:2467-2475.
20. Morrison J.A., Gulley M.L., Pathmanathan R., Raab-Traub N. Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 2004, 64:5251-5260.
21. Wang F.L., Guo X., Yuan T.Z., Cao S.M., Rao H.L., Hou J.H., et al. Expression and clinical significance of Wnt-1 and beta-catenin in nasopharyngeal carcinoma. Ai Zheng 2009, 28:72-75.
22. Xia H., Ng S.S., Jiang S., Cheung W.K., Sze J., Bian X.W., et al. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun 2010, 391:535-541.